<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01552265</url>
  </required_header>
  <id_info>
    <org_study_id>TRIAD1109</org_study_id>
    <nct_id>NCT01552265</nct_id>
  </id_info>
  <brief_title>Shanghai Mild Cognitive Impairment Cohort Study</brief_title>
  <official_title>Shanghai Cohort Study on Mild Cognitive Impairment for Early Detection of Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was planned 1) to identify individuals with Mild Cognitive Impairment (MCI) who
      convert to Alzheimer's Disease (AD), and 2) to explore factors associated with the
      conversion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">July 31, 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Conversion from MCI to &quot;Probable AD Dementia&quot;</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Conversion from MCI to &quot;Possible AD Dementia&quot; or &quot;Probable AD Dementia&quot;</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Conversion from MCI to &quot;All-cause Dementia&quot;</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Neuropsychological examinations</measure>
    <time_frame>baseline, annual and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in MRI</measure>
    <time_frame>baseline, annual and 3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">400</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>single-group MCI patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Cognitive concern reflecting a change in cognition reported by the patient or
             informant or clinician

          2. Mini-Mental State Examination (MMSE) scores between 18-30 (inclusive)

          3. Clinical Dementia Rating (CDR) =0.5; Memory Box score must be at least 0.5

          4. Objective memory loss* as evidenced by Auditory Verbal Learning test (AVLT-HS)

          5. Essentially preserved activities of daily living based on Alzheimer's Disease
             Cooperative Study - Activities of Daily Living (ADCS-ADL)

          6. Not-demented, as defined by '&quot;All-cause Dementia&quot; (see 3.4. All-cause Dementia)

          7. Willing to and able to undergo all test procedures including neuroimaging, and agree
             to longitudinal follow up

          8. Written informed consent for the participation of this study including repeated
             neuropsychological tests and MRI scans
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoji Nagai, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe,Japan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Huashan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.tri-kobe.org</url>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>Alzheimer's Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

